Ensuring Safe Handling, GMP Compliance & Cost-Effectiveness of Highly Potent & Cytotoxic Drugs Manufacturing
Event Dates
2024-06-25 - 2024-06-27
Organizer
Website
Exhibitors
25
Floor Size
0
Attendees
130
Event contact title
Contact
Event contact first name
.
Event contact last name
.
Email
info@hansonwade.com
Event contact telephone number
UK: +44 (0)20 3141 8700 / US: +1 617 455 4188
Description
With the increased complexity of novel molecules and rapid scale-up requirements, the 13th Process Development for High Potent Drugs Summit will return in 2024 with a heightened focus on:
- How industrial hygiene, occupational toxicology can strengthen collaboration with process safety and process development group to get it right first time – from process design to equipment selection to ensure a safe operating environment for workers
- Integration of internal and external stakeholders throughout drug development with case studies to expedite speed-to-clinic and market cost-effectively and with GMP compliance
- Robust quality and risk assessment, including OEL banding, environmental monitoring and containment technology, to protect workers’ safety